{"name":"Cellceutix Corporation","slug":"cellceutix-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Prurisol","genericName":"Prurisol","slug":"prurisol","indication":"Other","status":"phase_2"},{"name":"thioureidobutyronitrile","genericName":"thioureidobutyronitrile","slug":"thioureidobutyronitrile","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Prurisol","genericName":"Prurisol","slug":"prurisol","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"thioureidobutyronitrile","genericName":"thioureidobutyronitrile","slug":"thioureidobutyronitrile","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQd1BSdGNva0tpWmhrQ0lfb0F3M3JGX093cTRZczBURnhXVmkwU1VFenJVcndjM1o5X1dVc3YtekpmczhDdHVTSUJ1V3BGdUpvNHdyZElfZjh3V291MEhiYWFqNHp6NDRJZE12ZmRIR1EtajFndjJEUjVXYjJQNENUcnlvZ3FQR21mRHI5Uk9hNFc4U0RZc0Z1bmNB?oc=5","date":"2026-04-07","type":"regulatory","source":"openPR.com","summary":"Chronic Plaque Psoriasis Market Size is to Show Remarkable Growth Trends from 2024 to 2034, estimates DelveInsight - openPR.com","headline":"Chronic Plaque Psoriasis Market Size is to Show Remarkable Growth Trends from 2024 to 2034, estimates DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPN3NMeWt6WlQ0WnVaSFBfSVhmOG1URGNDV053SUpQU2Y1M2RIbXo1OVNRU1FDSlVGQlRPa0tYcTRkOXlKdWxOVDVOODhEOUFXWnh3YjZ3M0JYbFZGcXh4akEzNV9vSkFyaWQtWWtNZzBTdF9ydW5veFY3YmlIZ0pRZWlJRHpsbXpKbERqbnplMXgyT2p4Rnl2QzBqQ08?oc=5","date":"2024-08-19","type":"pipeline","source":"openPR.com","summary":"Skin Cancer Market SWOT Analysis by Size, Status and Forecast to 2024-2032 - openPR.com","headline":"Skin Cancer Market SWOT Analysis by Size, Status and Forecast to 2024-2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNbU8xWVdianc1djVkd2dWMTRPempBZ3FCMVU5SDN0T05yS0ZNWHhPbmxiMUtYMVpEZ2F2X2IyZ2Z5Y004Q1VmQmVrTjJzUzZkM1oxTlVwREJHelMyaExPNmk0ZHkzS1lrc2l0eXdkdDZPNDAxNkxPUV9tRHdvQi1nR1Z3dS1yQQ?oc=5","date":"2023-03-17","type":"pipeline","source":"Dermatology Times","summary":"Leon Kircik, MD, FAAD: The Evolving Acne Arsenal - Dermatology Times","headline":"Leon Kircik, MD, FAAD: The Evolving Acne Arsenal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQZWZJMDc4VUc5NFI0blJYd2ROWkFVYVpyWmJicWFRZlBrMGRaNVFJQ1FGVlliZTBEX19CUUVyeFgySVFibTduNWJSSkdxQ3d4UXVUdzhEbVVjbFotcmhDVjg3RF81RWxLeHc3ZWhHMVpDOFk3dHN1eERCem11TGNhSE1ubWJyY0FJMURnR3BPRGdqX0NHRjgwZXFKSm5ZRWFlRUc5TnEybk53bnZSa2hJUXFvZkw?oc=5","date":"2021-11-18","type":"pipeline","source":"Healio","summary":"Tazarotene, halobetasol combination efficacious in scalp psoriasis - Healio","headline":"Tazarotene, halobetasol combination efficacious in scalp psoriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPYkVBanFfRW1ESEJTREF2VGZVWDA3Z0l4YWJ3UVMwR2ZiX2RoN0FYUXdyWklOYU5BWHozYzY0NTJ0ZEFSbEdZM3NWOGlrbWhSc2pxZG1aSEVQR2FJWmpMNVdPckVrVHdnV0tYdVg3MmktelZKbFdQVG9aVTBFQzJDY3RhY1pCWG9zbTFSYnl3?oc=5","date":"2017-01-18","type":"pipeline","source":"BioPharma Dive","summary":"Cellceutix fires back against short-seller accusations - BioPharma Dive","headline":"Cellceutix fires back against short-seller accusations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1sLVdRUGhMVk9hcDloR0tYR3FPYl9Pd1NxdllEQjhGQWZXR1VmaE5yYl9CU05PSkUzYnRZUDZKbjNuOUdxbjFJQnBPb2o3QUM0cTV2d2RMNFMyRlpYd01vTUREQUY5S2J4Wk42Mm1OUWVpM2FHeG9sY1FTSQ?oc=5","date":"2016-12-15","type":"pipeline","source":"reuters.com","summary":"Stronger 'superbugs' expose lack of new drugs to fight them - reuters.com","headline":"Stronger 'superbugs' expose lack of new drugs to fight them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNWnpySFZ2WmE1RHNqeWZLcUNMQk9fMWJWWTZwczh0TmptU2ljT1QzaHVHY0lYdzYzSEFyNDI5aVFRY1lPNFFrOTBvZGxTX29wWjh1VUg4T0VXbFRhc19fV25zNm45dkpBajZPZ1A3WU1RaDhJeWFuZHlnRWVNeDVreVE2UDZIa0RZLVcwQXZPTjh5NE1U?oc=5","date":"2012-11-12","type":"trial","source":"Contract Pharma","summary":"Cellceutix, EU Site Sign Psoriasis Trial Pact - Contract Pharma","headline":"Cellceutix, EU Site Sign Psoriasis Trial Pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNU3I3dVZaQm5OY3VIcW5xNFVVOEpMci1qSGJSbjlPbHpPWkVBS2FaRFM1WmZKM1ZhclBYN1B0OUVlZHZ3aW0tVWNmM0Vab25aaW5UUzJPWVp1SkFzUHRia1F4blVqU1ZSS0VSZWI1ck5nNXNnVTZsTC1UNUI0SHd2MEhzbjE?oc=5","date":"2012-06-03","type":"pipeline","source":"Boston Herald","summary":"Jim Boeheim makes cancer startup play - Boston Herald","headline":"Jim Boeheim makes cancer startup play","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNNkhQNVE0dHNjS09XTkxxcEdMakh1aW9yS0dFNzFCQzR2THBOV1VMUDZiY3hHT0sxYjgtRk01di15ZGZlS2hqc2NKTnRfNEtDckdMMjlESXFzM1M1TFV5cUZCazBTZ3R4aWVOSGJqUU5ZazZDZV9lUTJfNkZXdkJuZlpCQVJDYjhjVVNTckswZXU?oc=5","date":"2012-05-30","type":"pipeline","source":"Syracuse.com","summary":"Syracuse basketball coach Jim Boeheim keeps working for cancer breakthrough - Syracuse.com","headline":"Syracuse basketball coach Jim Boeheim keeps working for cancer breakthrough","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}